|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Cash and cash equivalents | ||||||
| Current assets: | ||||||
| Cash and cash equivalents | ||||||
| Prepaid expenses | ||||||
| Total current assets | ||||||
| Prepaid expenses, non-current | ||||||
| Prepaid expenses, non-current | ||||||
| Investments in Trust Account | ||||||
| Total Assets | ||||||
| Liabilities and Stockholders’ Deficit | ||||||
| Current liabilities: | ||||||
| Due to related party | ||||||
| Promissory note - related party | ||||||
| Accounts payable and accrued expenses | ||||||
| Franchise tax payable | ||||||
| Income tax payable | ||||||
| Total current liabilities | ||||||
| Derivative warrant liabilities | ||||||
| Deferred underwriters’ discount | ||||||
| Total Liabilities | ||||||
| Class A common stock subject to possible redemption, $0.001 par value; 500,000,000 shares authorized; 22,164,744 shares issued and outstanding | ||||||
| Stockholders’ Deficit: | ||||||
| Class B common stock, $0.0001 par value; 50,000,000 shares authorized 5,541,186 shares issued and outstanding | ||||||
| Class B common stock, $0.0001 par value; 50,000,000 shares authorized; 5,750,000 shares issued and outstanding | ||||||
| Additional paid-in capital | ||||||
| Accumulated deficit | ||||||
| Stockholders’ Deficit | ||||||
| Total Liabilities and Stockholders’ Deficit |
Loading...
